First Wave BioPharma Inc (FWBI)
2.74
+0.01
(+0.37%)
USD |
NASDAQ |
Apr 26, 16:00
2.82
+0.08
(+2.92%)
After-Hours: 20:00
First Wave BioPharma Cash from Financing (TTM): 15.23M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.23M |
September 30, 2023 | 16.39M |
June 30, 2023 | 15.78M |
March 31, 2023 | 13.92M |
December 31, 2022 | 15.74M |
September 30, 2022 | 27.29M |
June 30, 2022 | 37.37M |
March 31, 2022 | 39.08M |
December 31, 2021 | 44.76M |
September 30, 2021 | 28.24M |
June 30, 2021 | 26.45M |
March 31, 2021 | 25.34M |
December 31, 2020 | 17.05M |
September 30, 2020 | 18.34M |
June 30, 2020 | 9.683M |
March 31, 2020 | 13.93M |
December 31, 2019 | 13.14M |
Date | Value |
---|---|
September 30, 2019 | 11.55M |
June 30, 2019 | 6.837M |
March 31, 2019 | 11.43M |
December 31, 2018 | 11.71M |
September 30, 2018 | 11.62M |
June 30, 2018 | 12.27M |
March 31, 2018 | 8.336M |
December 31, 2017 | 6.013M |
September 30, 2017 | 9.506M |
June 30, 2017 | 9.168M |
March 31, 2017 | 5.444M |
December 31, 2016 | 5.746M |
September 30, 2016 | 1.786M |
June 30, 2016 | 4.971M |
March 31, 2016 | 3.746M |
December 31, 2015 | 4.681M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
6.837M
Minimum
Jun 2019
44.76M
Maximum
Dec 2021
20.85M
Average
16.39M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
BioVie Inc | 15.36M |
Jaguar Health Inc | 34.23M |
Benitec Biopharma Inc | 27.96M |
Immuneering Corp | 28.44M |
NovaBay Pharmaceuticals Inc | 1.91M |